Haifeng Qiu

1.5k citations
31 papers · 1.0k indexed · h-index 22
Topics
Cancer-related molecular mechanisms research (13 papers)MicroRNA in disease regulation (10 papers)Circular RNAs in diseases (10 papers)
Partner nations
ChinaUnited States

In The Last Decade

Haifeng Qiu

30 papers receiving 1.0k citations

Peers

Haifeng Qiu
Comparison fields: 5 of 86
  • Molecular Biology 795
  • Cancer Research 637
  • Oncology 146
  • Pulmonary and Respiratory Medicine 69
  • Obstetrics and Gynecology 68
Replace Greg Khitrov with:
Greg Khitrov United States
Eva Schuster Austria
Annie Jean United States
Daniela Cimino Italy
Ka-Kei Ho United Kingdom
Chunping Qiu China
Even Birkeland Norway
Gloria Manzotti Italy
Fumiko Chiwaki Japan
Zhenfeng Zhang China
Haifeng Qiu relative to Greg Khitrov United States Greg Khitrov's profile →
Citations per field
00.5×4.2×
Greg Khitrov · 1×
Citations per year

Countries citing papers authored by Haifeng Qiu

Since Specialization
Citations

This map shows the geographic impact of Haifeng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Qiu more than expected).

Fields of papers citing papers by Haifeng Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haifeng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Qiu. The network helps show where Haifeng Qiu may publish in the future.

Co-authorship network of co-authors of Haifeng Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Haifeng Qiu. A scholar is included among the top collaborators of Haifeng Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haifeng Qiu. Haifeng Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 3
4 10
5 6
6 25
7 32
8 39
9 20
10 29
11 46
12 22
13 46
14 22
15 65
16 31
17 33
18 59
19 67
20 69

About Haifeng Qiu

Haifeng Qiu is a scholar working on Cancer Research, Molecular Biology and Developmental Neuroscience, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (10 papers) and Circular RNAs in diseases (10 papers). The work is most often cited by research in Cancer Research (637 citations), Molecular Biology (795 citations) and Obstetrics and Gynecology (68 citations). Haifeng Qiu has collaborated with scholars based in China and United States. Frequent co-authors include Jinjin Yu, Yuan Wang, Jing Li, Xiaoping Wan, Qiuli Liu, Wei Bao, Yuan Wang, Chunxiao Zhou, Victoria Bae‐Jump and Tingting Yang. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Sensors and Actuators B Chemical.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026